These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22941191)

  • 21. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.
    Russell MR; Penikis A; Oldridge DA; Alvarez-Dominguez JR; McDaniel L; Diamond M; Padovan O; Raman P; Li Y; Wei JS; Zhang S; Gnanchandran J; Seeger R; Asgharzadeh S; Khan J; Diskin SJ; Maris JM; Cole KA
    Cancer Res; 2015 Aug; 75(15):3155-66. PubMed ID: 26100672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ubiquitin ligase human TRIM71 regulates let-7 microRNA biogenesis via modulation of Lin28B protein.
    Lee SH; Cho S; Kim MS; Choi K; Cho JY; Gwak HS; Kim YJ; Yoo H; Lee SH; Park JB; Kim JH
    Biochim Biophys Acta; 2014 May; 1839(5):374-86. PubMed ID: 24602972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
    Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
    J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
    Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
    Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.
    Bell JL; Turlapati R; Liu T; Schulte JH; Hüttelmaier S
    J Clin Oncol; 2015 Apr; 33(11):1285-93. PubMed ID: 25753434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare variants in TP53 and susceptibility to neuroblastoma.
    Diskin SJ; Capasso M; Diamond M; Oldridge DA; Conkrite K; Bosse KR; Russell MR; Iolascon A; Hakonarson H; Devoto M; Maris JM
    J Natl Cancer Inst; 2014 Apr; 106(4):dju047. PubMed ID: 24634504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes.
    Ciuculete DM; Voisin S; Kular L; Jonsson J; Rask-Andersen M; Mwinyi J; Schiöth HB
    Clin Epigenetics; 2020 Jul; 12(1):99. PubMed ID: 32616021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.
    Liu Z; Yang X; Li Z; McMahon C; Sizer C; Barenboim-Stapleton L; Bliskovsky V; Mock B; Ried T; London WB; Maris J; Khan J; Thiele CJ
    Cell Death Differ; 2011 Jul; 18(7):1174-83. PubMed ID: 21252912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
    Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
    J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial DNA Haplogroups and Susceptibility to Neuroblastoma.
    Chang X; Bakay M; Liu Y; Glessner J; Rathi KS; Hou C; Qu H; Vaksman Z; Nguyen K; Sleiman PMA; Diskin SJ; Maris JM; Hakonarson H
    J Natl Cancer Inst; 2020 Dec; 112(12):1259-1266. PubMed ID: 32096864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas.
    Henrich KO; Bender S; Saadati M; Dreidax D; Gartlgruber M; Shao C; Herrmann C; Wiesenfarth M; Parzonka M; Wehrmann L; Fischer M; Duffy DJ; Bell E; Torkov A; Schmezer P; Plass C; Höfer T; Benner A; Pfister SM; Westermann F
    Cancer Res; 2016 Sep; 76(18):5523-37. PubMed ID: 27635046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
    Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
    Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association study in Taiwanese girls with precocious puberty.
    Chou IC; Wang CH; Lin WD; Tsai CH; Tsai FJ
    J Pediatr Endocrinol Metab; 2011; 24(1-2):103-4. PubMed ID: 21528826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma.
    Beckers A; Van Peer G; Carter DR; Gartlgruber M; Herrmann C; Agarwal S; Helsmoortel HH; Althoff K; Molenaar JJ; Cheung BB; Schulte JH; Benoit Y; Shohet JM; Westermann F; Marshall GM; Vandesompele J; De Preter K; Speleman F
    Cancer Lett; 2015 Sep; 366(1):123-32. PubMed ID: 26123663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase.
    Chen D; Cox J; Annam J; Weingart M; Essien G; Rathi KS; Rokita JL; Khurana P; Cuya SM; Bosse KR; Pilgrim A; Li D; Shields C; Laur O; Maris JM; Schnepp RW
    Neoplasia; 2020 Apr; 22(6):231-241. PubMed ID: 32339949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activating mutations in ALK provide a therapeutic target in neuroblastoma.
    George RE; Sanda T; Hanna M; Fröhling S; Luther W; Zhang J; Ahn Y; Zhou W; London WB; McGrady P; Xue L; Zozulya S; Gregor VE; Webb TR; Gray NS; Gilliland DG; Diller L; Greulich H; Morris SW; Meyerson M; Look AT
    Nature; 2008 Oct; 455(7215):975-8. PubMed ID: 18923525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional data support the role of
    Li Y; Zhuo ZJ; Zhou H; Liu J; Liu Z; Zhang J; Cheng J; Li S; Zhou H; Zhou R; He J; Zhao Y
    Aging (Albany NY); 2019 Apr; 11(8):2369-2377. PubMed ID: 31005956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma.
    Lozier AM; Rich ME; Grawe AP; Peck AS; Zhao P; Chang AT; Bond JP; Sholler GS
    Oncotarget; 2015 Jan; 6(1):196-206. PubMed ID: 25415050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Mitochondrial DNA Variants Associated With Risk of Neuroblastoma.
    Chang X; Liu Y; Glessner J; Hou C; Qu H; Nguyen K; Sleiman P; Lee L; Diskin SJ; Maris JM; Hakonarson H
    J Natl Cancer Inst; 2022 Jun; 114(6):910-913. PubMed ID: 35134187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.